Global Oral Vaccines Market Research Report 2017

Publisher Name :
Date: 13-Sep-2017
No. of pages: 113
Inquire Before Buying

In this report, the global Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Oral Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- GlaxoSmithKline Plc.

- PaxVax Corporation

- Pfizer Inc

- Merial, Inc.

- Merck Sharp & Dohme Corp

- VALNEVA Canada Inc.

- QUíMICA SUIZA S.A

- Immunitor, Inc

- Aventis (Sanofi S.A.)

- Serum Institute of India Pvt. Ltd

- Swiss Serum and Vaccine Institute Berne

- Bull Bio - NCIPD Ltd.

- Vaxart, Inc.

- Shantha Biotechnics

- Crucell (Janssen Global Services, LLC)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Live Attenuated Vaccines

- Killed/Inactivated Vaccines

- Recombinant Vaccines

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Vaccines for each application, including

- Polio

- Rabies

- Rotavirus

- Cholera

- HIV

- Respiratory Infections

- Influenza

- Tuberculosis

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Oral Vaccines Market Research Report 2017

Table of Contents
Global Oral Vaccines Market Research Report 2017
1 Oral Vaccines Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Oral Vaccines Segment by Type (Product Category)
1.2.1 Global Oral Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Oral Vaccines Production Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Others
1.3 Global Oral Vaccines Segment by Application
1.3.1 Oral Vaccines Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Polio
1.3.3 Rabies
1.3.4 Rotavirus
1.3.5 Cholera
1.3.6 HIV
1.3.7 Respiratory Infections
1.3.8 Influenza
1.3.9 Tuberculosis
1.3.10 Others
1.4 Global Oral Vaccines Market by Region (2012-2022)
1.4.1 Global Oral Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Oral Vaccines (2012-2022)
1.5.1 Global Oral Vaccines Revenue Status and Outlook (2012-2022)
1.5.2 Global Oral Vaccines Capacity, Production Status and Outlook (2012-2022)
2 Global Oral Vaccines Market Competition by Manufacturers
2.1 Global Oral Vaccines Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Oral Vaccines Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Oral Vaccines Production and Share by Manufacturers (2012-2017)
2.2 Global Oral Vaccines Revenue and Share by Manufacturers (2012-2017)
2.3 Global Oral Vaccines Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Oral Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oral Vaccines Market Competitive Situation and Trends
2.5.1 Oral Vaccines Market Concentration Rate
2.5.2 Oral Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Oral Vaccines Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Oral Vaccines Capacity and Market Share by Region (2012-2017)
3.2 Global Oral Vaccines Production and Market Share by Region (2012-2017)
3.3 Global Oral Vaccines Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Oral Vaccines Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Oral Vaccines Consumption by Region (2012-2017)
4.2 North America Oral Vaccines Production, Consumption, Export, Import (2012-2017)
4.3 Europe Oral Vaccines Production, Consumption, Export, Import (2012-2017)
4.4 China Oral Vaccines Production, Consumption, Export, Import (2012-2017)
4.5 Japan Oral Vaccines Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Oral Vaccines Production, Consumption, Export, Import (2012-2017)
4.7 India Oral Vaccines Production, Consumption, Export, Import (2012-2017)
5 Global Oral Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Oral Vaccines Production and Market Share by Type (2012-2017)
5.2 Global Oral Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global Oral Vaccines Price by Type (2012-2017)
5.4 Global Oral Vaccines Production Growth by Type (2012-2017)
6 Global Oral Vaccines Market Analysis by Application
6.1 Global Oral Vaccines Consumption and Market Share by Application (2012-2017)
6.2 Global Oral Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Oral Vaccines Manufacturers Profiles/Analysis
7.1 GlaxoSmithKline Plc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Oral Vaccines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 GlaxoSmithKline Plc. Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 PaxVax Corporation
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Oral Vaccines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 PaxVax Corporation Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Pfizer Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Oral Vaccines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Inc Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Merial, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Oral Vaccines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Merial, Inc. Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Merck Sharp & Dohme Corp
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Oral Vaccines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Merck Sharp & Dohme Corp Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 VALNEVA Canada Inc.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Oral Vaccines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 VALNEVA Canada Inc. Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 QUíMICA SUIZA S.A
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Oral Vaccines Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 QUíMICA SUIZA S.A Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Immunitor, Inc
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Oral Vaccines Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Immunitor, Inc Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Aventis (Sanofi S.A.)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Oral Vaccines Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Aventis (Sanofi S.A.) Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Serum Institute of India Pvt. Ltd
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Oral Vaccines Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Serum Institute of India Pvt. Ltd Oral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Swiss Serum and Vaccine Institute Berne
7.12 Bull Bio - NCIPD Ltd.
7.13 Vaxart, Inc.
7.14 Shantha Biotechnics
7.15 Crucell (Janssen Global Services, LLC)
8 Oral Vaccines Manufacturing Cost Analysis
8.1 Oral Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oral Vaccines
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Oral Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Oral Vaccines Market Forecast (2017-2022)
12.1 Global Oral Vaccines Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Oral Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Oral Vaccines Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Oral Vaccines Price and Trend Forecast (2017-2022)
12.2 Global Oral Vaccines Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Oral Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Oral Vaccines Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Oral Vaccines Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Oral Vaccines
Figure Global Oral Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Oral Vaccines Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Live Attenuated Vaccines
Table Major Manufacturers of Live Attenuated Vaccines
Figure Product Picture of Killed/Inactivated Vaccines
Table Major Manufacturers of Killed/Inactivated Vaccines
Figure Product Picture of Recombinant Vaccines
Table Major Manufacturers of Recombinant Vaccines
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Oral Vaccines Consumption (K Units) by Applications (2012-2022)
Figure Global Oral Vaccines Consumption Market Share by Applications in 2016
Figure Polio Examples
Table Key Downstream Customer in Polio
Figure Rabies Examples
Table Key Downstream Customer in Rabies
Figure Rotavirus Examples
Table Key Downstream Customer in Rotavirus
Figure Cholera Examples
Table Key Downstream Customer in Cholera
Figure HIV Examples
Table Key Downstream Customer in HIV
Figure Respiratory Infections Examples
Table Key Downstream Customer in Respiratory Infections
Figure Influenza Examples
Table Key Downstream Customer in Influenza
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Oral Vaccines Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Oral Vaccines Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Oral Vaccines Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Oral Vaccines Major Players Product Capacity (K Units) (2012-2017)
Table Global Oral Vaccines Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Oral Vaccines Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Oral Vaccines Capacity (K Units) of Key Manufacturers in 2016
Figure Global Oral Vaccines Capacity (K Units) of Key Manufacturers in 2017
Figure Global Oral Vaccines Major Players Product Production (K Units) (2012-2017)
Table Global Oral Vaccines Production (K Units) of Key Manufacturers (2012-2017)
Table Global Oral Vaccines Production Share by Manufacturers (2012-2017)
Figure 2016 Oral Vaccines Production Share by Manufacturers
Figure 2017 Oral Vaccines Production Share by Manufacturers
Figure Global Oral Vaccines Major Players Product Revenue (Million USD) (2012-2017)
Table Global Oral Vaccines Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Oral Vaccines Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Oral Vaccines Revenue Share by Manufacturers
Table 2017 Global Oral Vaccines Revenue Share by Manufacturers
Table Global Market Oral Vaccines Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Oral Vaccines Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Oral Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Oral Vaccines Product Category
Figure Oral Vaccines Market Share of Top 3 Manufacturers
Figure Oral Vaccines Market Share of Top 5 Manufacturers
Table Global Oral Vaccines Capacity (K Units) by Region (2012-2017)
Figure Global Oral Vaccines Capacity Market Share by Region (2012-2017)
Figure Global Oral Vaccines Capacity Market Share by Region (2012-2017)
Figure 2016 Global Oral Vaccines Capacity Market Share by Region
Table Global Oral Vaccines Production by Region (2012-2017)
Figure Global Oral Vaccines Production (K Units) by Region (2012-2017)
Figure Global Oral Vaccines Production Market Share by Region (2012-2017)
Figure 2016 Global Oral Vaccines Production Market Share by Region
Table Global Oral Vaccines Revenue (Million USD) by Region (2012-2017)
Table Global Oral Vaccines Revenue Market Share by Region (2012-2017)
Figure Global Oral Vaccines Revenue Market Share by Region (2012-2017)
Table 2016 Global Oral Vaccines Revenue Market Share by Region
Figure Global Oral Vaccines Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Oral Vaccines Consumption (K Units) Market by Region (2012-2017)
Table Global Oral Vaccines Consumption Market Share by Region (2012-2017)
Figure Global Oral Vaccines Consumption Market Share by Region (2012-2017)
Figure 2016 Global Oral Vaccines Consumption (K Units) Market Share by Region
Table North America Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Oral Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Oral Vaccines Production (K Units) by Type (2012-2017)
Table Global Oral Vaccines Production Share by Type (2012-2017)
Figure Production Market Share of Oral Vaccines by Type (2012-2017)
Figure 2016 Production Market Share of Oral Vaccines by Type
Table Global Oral Vaccines Revenue (Million USD) by Type (2012-2017)
Table Global Oral Vaccines Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Oral Vaccines by Type (2012-2017)
Figure 2016 Revenue Market Share of Oral Vaccines by Type
Table Global Oral Vaccines Price (USD/Unit) by Type (2012-2017)
Figure Global Oral Vaccines Production Growth by Type (2012-2017)
Table Global Oral Vaccines Consumption (K Units) by Application (2012-2017)
Table Global Oral Vaccines Consumption Market Share by Application (2012-2017)
Figure Global Oral Vaccines Consumption Market Share by Applications (2012-2017)
Figure Global Oral Vaccines Consumption Market Share by Application in 2016
Table Global Oral Vaccines Consumption Growth Rate by Application (2012-2017)
Figure Global Oral Vaccines Consumption Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc. Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Production Market Share (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Revenue Market Share (2012-2017)
Table PaxVax Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PaxVax Corporation Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PaxVax Corporation Oral Vaccines Production Growth Rate (2012-2017)
Figure PaxVax Corporation Oral Vaccines Production Market Share (2012-2017)
Figure PaxVax Corporation Oral Vaccines Revenue Market Share (2012-2017)
Table Pfizer Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Oral Vaccines Production Growth Rate (2012-2017)
Figure Pfizer Inc Oral Vaccines Production Market Share (2012-2017)
Figure Pfizer Inc Oral Vaccines Revenue Market Share (2012-2017)
Table Merial, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merial, Inc. Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial, Inc. Oral Vaccines Production Growth Rate (2012-2017)
Figure Merial, Inc. Oral Vaccines Production Market Share (2012-2017)
Figure Merial, Inc. Oral Vaccines Revenue Market Share (2012-2017)
Table Merck Sharp & Dohme Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme Corp Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Production Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Production Market Share (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Revenue Market Share (2012-2017)
Table VALNEVA Canada Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table VALNEVA Canada Inc. Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Production Growth Rate (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Production Market Share (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Revenue Market Share (2012-2017)
Table QUíMICA SUIZA S.A Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table QUíMICA SUIZA S.A Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Production Growth Rate (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Production Market Share (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Revenue Market Share (2012-2017)
Table Immunitor, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunitor, Inc Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunitor, Inc Oral Vaccines Production Growth Rate (2012-2017)
Figure Immunitor, Inc Oral Vaccines Production Market Share (2012-2017)
Figure Immunitor, Inc Oral Vaccines Revenue Market Share (2012-2017)
Table Aventis (Sanofi S.A.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aventis (Sanofi S.A.) Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Production Growth Rate (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Production Market Share (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Revenue Market Share (2012-2017)
Table Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute of India Pvt. Ltd Oral Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Production Growth Rate (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Production Market Share (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure Global Oral Vaccines Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Oral Vaccines Price (Million USD) and Trend Forecast (2017-2022)
Table Global Oral Vaccines Production (K Units) Forecast by Region (2017-2022)
Figure Global Oral Vaccines Production Market Share Forecast by Region (2017-2022)
Table Global Oral Vaccines Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Oral Vaccines Consumption Market Share Forecast by Region (2017-2022)
Figure North America Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Oral Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Oral Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Oral Vaccines Production (K Units) Forecast by Type (2017-2022)
Figure Global Oral Vaccines Production (K Units) Forecast by Type (2017-2022)
Table Global Oral Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Oral Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Global Oral Vaccines Price Forecast by Type (2017-2022)
Table Global Oral Vaccines Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Oral Vaccines Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • EMEA All Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 25-Sep-2017        Price: US 4480 Onwards        Pages: 122
    A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorgani......
  • Global Ibs-C Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 123
    Key Findings The global IBS-C drug market is forecasted to grow at a CAGR of 6.95% between the years 2017 - 2025. Some of the primary factors responsible for the growth in this market are the ease of availability of effective drugs in the market, modern dietary habits affecting the health, various psychological factors leading to irritable bowel syndrome and the potential use of the improved and efficient drugs that are currently in the pipelines. Market Insights The global ......
  • Asia-Pacific Ibs-C Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 66
    Key Finding The Asia-Pacific IBS-c drug market is predicted to grow at a CAGR of 8.85% over the forecast period of 2017-2025 and generate an estimated revenue of $875 million by the end of 2025. The high unmet needs for the drugs in the Asian region leading to a subsequent higher demand from the market are expected to boost the market growth in the coming years Market Insights IBS being a heritable condition in some of the population, the poor and unhealthy eating ha......
  • Europe Ibs-C Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 665
    Key Findings The Europe IBS-c drug market is expected to grow at a CAGR of 7.37% over the forecast period of 2017-2025. The market was valued at $784 million in the year 2016, and the market worth is set to optimize up to $1473 million by the end of 2025. Market Insights The European market is mainly driven by factors such as unhealthy eating habits, improved and efficient drugs in the pipeline and the easy availability of the drug in the European market. The segmentation of......
  • Asia Pacific Pharmaceutical Desiccant Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 59
    Key Findings The Asia Pacific Pharmaceutical desiccant market is predicted to rise at a CAGR of 4.56% over the forecast period of 2017-2025. The revenue generated by the market is expected to reach $43738 thousand by the end of 2025. Market Insights The market is segmented based on the end-uses and the type. The various end-uses for this market include diagnostic kit, nutraceutical product packaging, capsules, and APIs. The market segment by type is categorized into molecula......
  • Europe Pharmaceutical Desiccant Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 58
    Key Findings The Europe Pharmaceutical desiccant market was valued at $ 33013 thousand in 2016. The market is anticipated to rise at a CAGR of 4.29% over the forecast period of 2017- 2025, generating $48279 million by its end. Market Insights The rapid growth of the pharmaceutical market and the continuous rise in the elderly population are two of the most important factor propelling the market growth. The market segments include by type and by the end-use. The marke......
  • North America Pharmaceutical Desiccant Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 62
    Key Findings The North America pharmaceutical desiccant market is projected to grow at a 4.36% CAGR, generating a revenue of $53890 thousand by the end of the forecast period of 2017- 2025. Market Insights The North American region is currently leading the global markets for Pharmaceutical desiccant. The market is segmented on the basis of type and end-use. The market finds its application in major industries like pharmaceutical, oil and gas, petrochemical, etc. The pharmace......
  • North America Ibs-C Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 69
    Key Findings The North American IBS-C drug market was valued at $1113 million in 2016. The market is expected to grow at a CAGR of 5.51% and generate $1818 million by the end 2025. The advanced medical and healthcare facility in the US and Canada, along with the continuous support from federal agencies and private medical firms are propelling the market in this region. Market Insights The market segments include drug type and prescription type. The market segment by drug typ......
  • Global Pharmaceutical Desiccant Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 112
    Key Findings The Global Pharmaceutical desiccant market is predicted to rise with a CAGR of 4.40% over the forecast period of 2017- 2025, generating a revenue of $180133 thousand by the end of 2025. The market is chiefly being driven by factors such as growing aging population, various initiatives undertaken by the government to ensure the quality of drugs, and the expanding pharmaceutical market. Market Insights The Global Pharmaceutical Desiccants market is segmented based......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs